8. Literaturverzeichnis
Abelman WH, Lorrell BH: The challenge of cardiomyopathy. J Am Coll Cardiol (1989) 13: 1219
Abraham LJ, French MA, Dawkins RL: Polymorphic MHC ancestral haplotypes affect the activity of tumour necrosis factor-alpha. Clin Exp Immunol (1993) 92(1):14-18
Abraham LJ, Kroeger KM: Impact of the -308 TNF promoter polymorphism on the transcriptional regulation of the TNF gene: relevance to disease. J Leukoc Biol (1999) 66(4): 562-566
Adamopoulos S, Parissis JT, Paraskevaidis I, Karatzas D, Livanis E, Georgiadis M, Karavolias G, Mitropoulos D, Degiannis D, Kremastinos DT: Effects of growth hormone on circulating cytokine network, and left ventricular contractile performance and geometry in patients with idiopathic dilated cardiomyopathy. Eur Heart J (2003) 24:2186-2196
Aggarwal BB, Natarajan K: Tumor necrosis factors: developments during the last dec-ade. Eur Cytokine Network. (1996) 7:93-124
Aguillón JC, Cruzat A, Aravena O, Salazar L, Llanos C, Cuchacovich M: Could single-nucleoide polymorphism (SNPs) affecting the tumor necrosis factor promoter be con-sidered as part of rheumatoid arthritis evolution? Immunobiology (2006) 211(1-2):75-84
Ahmad S, Rai TS, Khullar M, Bahl A, Saikia UN, Thungapathra M, Kumar RM, Mahajan R, Talwar KK: Decreased myocardial expression of dystrophin and titin mRNA and protein in in dilated cardiomyopathy: possiblyan adverse effect of TNF-alpha. J Clin Immunol (2010) ;30(4):520-530
Alikasifoglu M, Tokgözoglu L, Acil T, Atalar E, Ali Oto M, Sirri Kes S, Tuncbilek E:
Tumor necrosis factor-alpha polymorphism in Turkish patients with dilated cardiomyo-pathy. Eur J Heart Fail (2003) 5(2):161-163
8. Literaturverzeichnis
Al-Shobaili HA, Salem TA, Alzolibani AA, Robaee AA, Settin AA: Tumor necrosis factor-α -308 G/A and interleukin 10 -1082 A/G gene polymorphisms in patients with acne vulgaris. J Dermatol Sci. (2012) 68 (1) 52-55
Anker SD, Egerer KR, Volk HD, Kox WJ, Poole-Wilson PA, Coats AJ: Elevated solu-ble CD14 receptors and altered cytokines in chronic heart failure. Am J Cardiol (1997) 79:1426-1430
Asadullah K, Docke WD, Sabat R, Ebeling M, Volk HD, Sterry W: Interleukin-10 in dermatology. Hautarzt. (1999) 50(1):12-19
Aukrust P, Ueland T, Lien E, Bendtzen K, Müller F, Andreassen AK, Nordøy I, Aass H, Espevik T, Simonsen S, Frøland SS, Gullestad L: Cytokine network in congestive heart failure secondary to ischemic or idiopathic dilated cardiomyopathy. Am J Cardiol (1999) 83:376-382
Aziz T, Burgess M, Rahman AN, Campbell CS, Yonan N: Cardiac transplantation for cardiomyopathy and ischemic heart disease: differences in outcome up to 10 years. J heart lung transplant (2000) 20: 525-533
Barrett KE: Cytocines: sources, receptors and signalling. Bailliere Clin Gastroenterol (1996) 10 (1): 1-10
Bazzoni F, Beutler B: Seminars in medicine of the Beth Israel Hospital, Boston: the tumor necrosis factor ligand and receptor families. N Engl J Med (1996) 334: 1717-1725
Beutler B, Cerami A: Tumor necrosis, cachexia, shock, and inflammation: a common mediator. Annu Rev Biochem (1988) 57: 505-518
Beutler B; Cerami A: The biology of cachectin/TNF-a primary mediator of the host response. Annu Rev Immunol (1989) 7: 625-655
8. Literaturverzeichnis
Beutler B, Brown T: Polymorphism of the mouse TNF-alpha locus: sequence studies of the 30-untranslated region and first intron. Gene (1993) 129: 279-283
Berhane N, Sobti RC, Melesse S, Mahdi SA, Kassu A: Significance of Tumor Necrosis factor α-308 (G/A) gene polymorphism in the development of prostate cancer. Mol Biol Rep (2012) 39(12):11125-11130
Beyaert R; Fiers W: Tumor necrosis factor and lymphotoxin. Cytokine (1998) 24: 335-359
Bienvenu J, Doche C, Gutowski MC, Lenoble M, Lepape A, Perdrix JP. Production of proinflammatory cytokines and cytokines involved in the TH1/TH2 balance is modulat-ed by pentoxifylline. J Cardiovasc Pharmacol (1995) 25: 80-84
Bogdan C, Vodovotz Y, Nathan C: Macrophage deactivation by interleukin 10. J Exp Med (1999) 174:1549-1555
Bolger AP, Anker SD: Tumour necrosis factor in chronic heart failure: a peripheral view on pathogenesis, clinical manifestations and therapeutic implications. Drugs (2000) 60: 1245–1257
Bouma G, Crusius JBA, Oudkerk-Pool M, Kolkman JJ, Vonblomberg BME, Kostense PJ, Giphart MJ, Schreuder MTH, Meuwissen SGM,Pena AS: Secretion of tumour ne-crosis factor and lymphotoxin in relation to polymorphisms in the TNF genes and HLA-DR alleles. Relevance for inflammatory bowel diseases. Scand. J Immunol (1996) 43:456-463
Bozkurt B, Kribbs S, Clubb FJ Jr, Michael LH, Didenko VV, Hornsby PJ, Seta Y, Oral H, Spinale FG, Mann DL: Pathophysiologically relevant concentrations of tumor necro-sis factor- a promote progressive left ventricular dysfunction and remodeling in rats.
Circulation. (1998) 97:1382-1391
8. Literaturverzeichnis
Bozkurt B, Torre-Amione G, Warren MS, Whitmore J, Soran OZ, Feldman AM, Mann DL: Results of targeted anti–tumor necrosis factor therapy with etanercept (ENBREL) in patients with advanced heart failure. Circulation (2001) 103:1044-1047
Breunan FM, Maini RN, Feldman M: TNFa: a pivotal role in rheumatoid arthritis. Br J Rheumatol (1992) 31:293-298
Brookes AJ: The essence of SNPs. Gene (1999) 234(2):177-186
Bryant D, Becker L, Richardson J, Shelton J, Franco F, Peshock R, Thompson M, Giroir B: Cardiac failure in transgenic mice with myocardial expression of tumor necro-sis factor-alpha. Circulation (1998) 97:1375-1381
Cabrera M, Shaw M-A, Sharples C, Williams H, Castes M, Convit J, Zlackwell JM:
Polymorphism in tumor necrosis factor genes associated with mucocutaneous leishman-iasis. J Exp Med (1995) 182:1259-1264
Caforio AL, Mahon NG, Baig MK, Tona F, Murphy RT, Elliott PM, McKenna WJ:
Prospective familial assessment in dilated cardiomyopathy: cardiac autoantibodies pre-dict disease development in asymptomatic relatives. Circulation (2007) 115(1):76-83
Callard R, George AJ, Stark J. Cytokines, chaos and complexity: Immunity (1999) 11:
507-513
Candore G, Cigna D, Gervasi F, Colucci AT, Modica MA, Caruso C: In vitro cytokine production by HLA-B8,DR3 positive subjects. Autoimmunity (1994) 18:121-132
Carswell EA, Old LJ, Kassel RL, Green S, Fiore N, Williamson B: (1975) An endotoxin -induced serum factor that causes necrosis of tumors. Proc Natl Acad Sci USA (1975) 72: 3666–3670
Castro-Santos P, Suarez A, López-Rivas L, Mozo L, Gutierrez C: TNF alpha and IL-10 gene polymorphisms in inflammatory bowel disease. Assoziation of -IL-1082 AA low
8. Literaturverzeichnis
producer IL-10 genotype with steroid dependency. Am J Gastroenterol (2006) 101(5):1039-1047
Ceconi C, Curello S, Bachetti T, Corti A, Ferrari R: Tumor necrosis factor in congestive heart failure: a mechanism of disease for the new millennium? Prog Cardiovasc Dis (1998) 41(1):25-30
Chatterjee R, Batra J, Kumar A, Mabalirajan U, Nahid S, Niphadkar PV, Ghosh B: In-terleukin-10-promotor-polymorhisms and atopic asthma in North Indians. Clin Exp Al-lergy (2005) 35(7):914-919
Chen G, Goeddel DV: TNF-R1 signaling: A beautiful pathway. Science (2002) 296:1634-1635
Clark DN, Markham JL, Sloan CS, Poole BD: Cytokine inhibition as a strategy for treating systemic lupus erythematosus. Clin Immunol (2012) 1521-6616
Codd MB, Sugrue DD, Gersh BJ, Melton LJ: Epidemiology of idiopathic dilated and hypertrophic cardiomyopathy. Circulation (1989) 80: 564-572
Cooper LT, Baughman KL, Feldman AM, Frustaci A, Jessup M, Kuhl U, Levine GN, Narula J, Starling RC, Towbin J, Virmani R; American Heart Association; American College of Cardiology; European Society of Cardiology: The role of endomyocardial biopsy in the management of cardiovascular disease: a scientific statement from the American Heart Association, the American College of Cardiology, and the European Society of Cardiology. Circulation (2007) 116(19):2216-2233
Cordeiro CA, Moreira PR, Andrade MS, Dutra WO, Campos WR, Oréfice F, Teixeira AL: Interleukin-10 gene polymorphism (-1082G/A) is associated with toxoplasmic reti-nochoroiditis. Invest Ophthalmol Vis Sci (2008) 49(5):1979-1982
Cowie MR, Mosterd A, Wood DA, Deckers JW, Poole-Wilson PA, Sutton GC, Grobbee DE: The epidemiology of heart failure. Eur Heart J (1997) 18: 208-225
8. Literaturverzeichnis
Crawley E, Kay R, Sillibourne J, Patel P, Hutchinson I, Woo P: Polymorphic haplo-types of the interleukin-10 5' flanking region determine variable interleukin-10 tran-scription and are associated with particular phenotypes of juvenile rheumatoid arthritis.
Arthritis Rheum (1999) 42(6):1101-1108
Cuenca J, Cuchacovich M, Perez C, Ferreira L, Aguirre A, Schiattino I, Soto L, Cruzat A, Salazar-Onfray F, Aguillon JC: The -308 polymorphism in the tumour necrosis fac-tor gene promoter region and ex vivo lipopolysaccharide-induced TNF expression and cytotoxic activity in Chilean patients with rheumatoid arthritis. Rheumatology (2003) 42:308-313
D’Alfonso S, Richiardi PM: A polymorphic variation in a putative regulation box of the TNFA promoter region. Immunogenetics (1994) 39(2):150-154
Anderson GM, Nakada MT, DeWitte M: Tumor necrosis factoralpha in the pathogene-sis and treatment of cancer. Curr Opin Pharmacol (2004) 4:314-320
Damas JK, Gullestad L, Aukrust P: Cytokines as new treatment targets in chronic heart failure. Curr Control Trials Cardiovasc Med (2001) 2:271–277
Dandona P, Mohanty P, Hamouda W, Aljada A, Kumbkarni Y, Garg R: Effect of dex-amethasone on reactive oxygen species generation by leukocytes and plasma interleu-kin-10 concentrations: a pharmacodynamic study. Clin Pharmacol Ther (1999) 66:58-65
Davis JM, Narachi MA, Alton K, Arakawa T: Structure of human tumor necrosis fac-tor-a derived from recombinant DNA. Biochemistry (1987) 26:1322-1326
Dec GW, Fuster V: Medical Progress: Idiopathic Dilated Cardiomyopathy. N England j med (1994) 23: 1564 – 1575
Dembic Z, Loetscher H, Gubler U, Pan YC, Lahm HW, Gentz R, Brockhaus M, Less-lauer W. Two human TNF receptors have similar extracellular, but distinct intracellular, domain sequences. Cytokine (1990) 2:231–7
8. Literaturverzeichnis
Deswal A, Bozkurt B, Seta Y, Parilti-Eiswirth S, Hayes FA, Blosch C, Mann DL: A phase I trial of tumor necrosis factor receptor (p75) fusion protein (TNFR:Fc) in pa-tients with advanced heart failure. Circulation (1999) 99:3224–3226
Deswal A, Petersen NJ, Feldman AM, Young JB, White BG, Mann DL: Cytokines and cytokine receptors in advanced heart failure: an analysis of the cytokine database from the Vesnarinone trial (VEST). Circulation (2001) 103:2055-2059
De Simone C, Carbone A, Caldarola G: Etanercept therapy for psoriasis in a patient with numerous comorbidities. Am J Clin Dermatol (2010) 1:49-50
De Waal Malefyt R, Abrams J, Bennett B, Figdor CG, de Vries JE: Interleukin 10 (IL-10) inhibits cytokine synthesis by human monocytes: an autoregulatory role of IL-10 produced by monocytes. J Exp Med (1991a) 174(5):1209-1202
De Waal Malefyt R, Haanen J, Spits H, Roncarolo MG, Velde A te, Figdor C, Johnson K, Kastelein R, Yssel H, de Vries JE: Interleukin 10 (IL-10) and viral IL-10 strongly reduce antigenspecific human T cell proliferation by diminishing the antigenpresenting capacity of monocytes via downregulation of class II major histocompatibility complex expression. J Expel Med (1991b) 174:915
Diaz RA, Obasohan A, Oakley CM: Prediction of outcome of dilated cardiomyopathy.
Br Heart J (1987) 58:393-399
Donger C, Georges JL, Nicaud V, Morrison C, Evans A, Kee F, Arveiler D, Tiret L, Cambien F: New polymorphisms in the interleukin-10 gene - relationships to myocardi-al infarction. Eur J Clin Invest (2001)31(1):9-14
Doyama K, Fujiwara H, Fukumoto M, Tanaka M, Fujiwara Y, Oda T, Inada T, Ohtani S, Hasegawa K, Fujiwara T, Sasayama S: Tumour necrosis factor is expressed in cardi-ac tissues of patients with heart failure. Int J Cardiol (1996) 54:217-225
Dutka DP, Elborn JS, Delamere F, Shale DJ, Morris GK: Tumour necrosis factor-alpha in severe congestive cardiac failure. Br Heart J (1993) 70:141-143
8. Literaturverzeichnis
Economou JS, Rhoades K, Essner R, McBride WH, Gasson JC, Morton DL: Genetic analysis of the human tumor necrosis factor α cachectin promoter region in a macro-phage cell line. J Exp Med (190) 170: 321-326
El Azab SR, Rosseel PM, de Lange JJ et al.: Dexamethasone decreases the pro- to anti inflammatory cytokine ratio during cardiac surgery. Br J Anaesth (2002) 88:496–501
Elahi MM, Asotra K, Matata BM, Mastana SS: Tumor necrosis factor alpha -308 gene locus promoter polymorphism: an analysis of association with health and disease. Bio-chim Biophys Acta (2009) 1792(3):163-72
Elliott P, Andersson B, Arbustini E, Bilinska Z, Cecchi F, Charron P, Dubourg O, Kühl U, Maisch B, McKenna WJ, Monserrat L, Pankuweit S, Rapezzi C, Seferovic P, Tavaz-zi L, Keren A: Classification of the cardiomyopathies: a positon statement from the eu-ropean society of cardiology working group on myocardial and pericardial diseases. Eur Heart J (2008) 29: 270-276
Engelmann H, Holtmann H, Brakebusch C et al.: Antibodies to a soluble form of a tu-mor necrosis factor (TNF) receptor have TNF-like activity. J Biol Chem (1990) 265:
14497–14504
Eskdale J, Gallagher G, Verweij CL, Keijsers V, Westendorp RG, Huizinga TW: Inter-leukin 10 secretion in relation to IL-10 locus haplotypes. Proc Natl Acad Sci USA (1998) 95:9465-9470
Eskdale J, Keijsers V, Huizinga T, Gallagher G: Microsatellite alleles and single nu-cleotide polymorphisms (SNP) combine to form four major haplotype families at the human interleukin-10 (IL-10) locus. Genes Immunity (1999)1: 151-155
Everly MJ: Cardiac transplantation in the United States: an analysis of the UNOS regis-try. Clin Transpl (2008) 35–43
Fedorak RN, Gangl A, Elson CO, et al: Recombinant human interleukin 10 in the treat-ment of patients with mild to moderately active Crohn's disease. The Interleukin 10
in-8. Literaturverzeichnis
flammatory bowel disease cooperative study group. Gastroenterology (2000) 119:1473-82
Feldman AM, Combes A, Wagner D, Kadakomi T, Kubota T, Li YY et al: The role of tumor necrosis factor in the phathophysiology of heart failure. J Am Coll Cardiol (2000) 35:537-544
Felker GM, Thompson RE, Hare JM, Hruban RH, Clemetson DE, Howard DL, Baugh-man KL, Kasper EK: Underlying causes and long-term survival in patients with initially unexplained cardiomyopathy. N England j med (2000) 342 (15): 1077-1084
Ferrari R, Bachetti T, Confortini R, Opasich C, Febo O, Corti A, Cassani G, Visioli O:
Tumor necrosis factor soluble receptors in patients with various degrees of congestive heart failure. Circulation (1995) 92: 1479-1486
Finbloom DS, Winestock KD: IL-10 induces the tyrosine phosphorylation of tyk2 and Jak1 and the differential assembly of STAT1-α and STAT3 complexes in human T cells and monocytes. J Immunol (1995) 155:1079-1090
Finkel MS, Oddis CV, Jacob TD, Watkins SC, Hattler BG, Simmons RL: Negative ino-tropic effects of cytokines on the heart mediated by nitric oxide. Science (1992) 257:
387-389
Fiorentino DF, Bond MW, Mosmann TR: Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med (1989) 170(6):2081-2095
Fiorentino DF, Zlotnik A, Vieira P, Mosmann TR, Howard M, Moore KW, O'Garra A:
ILl0 acts on the antigen presenting cell to inhibit cytokine production by Thl cells. J Immunol (1991) 146:3444
Fichtlscherer S, Rössig L, Breuer S, Vasa M, Dimmeler S, Zeiher AM: Tumor necrosis factor antagonism wirh etanercept improves systemic endothelial voasoreactivity in patients with advanced heart failure. Circulation (2001) 104(25):3023-3025
8. Literaturverzeichnis
Fu M, Matusi S: Is cardiomyopathy an autoimmune disease? Keio J Med (2002) 51:208-212
Giomarelli P, Scolletta S, Borrelli E, Biagioli B: Myocardial and lung injury after cardi-opulmonary bypass: role of interleukin (IL)-10. Ann Thorac Surg (2003) 76:117-123
Giroir BP, Johnson JH, Brown T, Allen GL, Beutler B: The tissue distribution of tumor necrosis factor biosynthesis during endotoxemia. J Clin Invest (1992) 90:693-698
Go NF, Castle BE, Barrett R, Kastelein R, Dang W, Mosmann TR, Moore KW, Howard M: Interleukin 10, a novel B cell stimulatory factor: unresponsiveness of X chromo-some-linked immunodeficiency B cells. J Exp Med (1990) 172(6):1625-1631
Golfeld AE, Doyle C, Maniatis T: Human tumor necrosis factor α gene regulation by virus and lipopolysaccharide. Proc Natl Acad Sci USA (1990) 87: 9769-9773
Golfeld AE, Strominger JL, Doyle C: Human tumor necrosis factor α gene regulation in phorbol ester stimulated T and B cell lines. J Exp Med (1991) 174:73-81
Gomez-Reino JJ, Carmona L, Valverde VR, Mola EM, Montero MD: Treatment of rheumatoid arthritis with tumor necrosis factor inhibitors may predispose to significant increase in tuberculosis risk: a multicenter active-surveillance report. Arthritis Rheum (2003) 48:2122-2127
Grogan M, Redfield MM, Bailey KR, Reeder GS, Gersh BJ, Edwards WD, Rodeheffer RJ: Long-term outcome of patients with biopsy-proved myocarditis: comparison with idiopathic dilated cardiomyopathy. J Am Coll Cardiol (1995) 26: 80 – 84
Gregori D, Rosato R, Zecchin M, Baldi I, Di Lenarda A: Heart failure and sudden death in dilated cardiomyopathy: a hidden competition we should not forget about when mod-elling mortality. J Eval Clin Pract (2008) 1:53-58
Grünig E, Tasman JA, Kücherer H, Franz W, Kübler W, Katus H: Frequency and phe-notypes of familial dilated cardiomyopathy. J Am Coll Cardiol (1998) 31: 186 – 194
8. Literaturverzeichnis
Habib FM, Springall DR, Davies GJ, Oakley CM, Yacoub MH, Polak JM: Tumour ne-crosis factor and inducible nitric oxide synthase in dilated cardiomyopathy. Lancet (1996) 347:1151-1155
Han J, Brown T, Beutler B: Endotoxin-responsive sequences control cachectin/tumor necrosis factor biosynthesis at the translational level. J Exp Med (1990) 171: 465-475
Han J, Huez G, Beutler B: Interactive effects of the tumor necrosis factor promoter and 3’untranslated regions. J Immunol (1991) 146: 1843-1848
Hajeer AH, Hutchinson IV: TNF-α gene polymorphism: clinical and biological implica-tions. Microsc Res Tech (2000) 50 (3): 216-228
Hajeer AH, Hutchinson IV: Influence of TNFalpha gene polymorphisms on TNFalpha production and disease. Hum Immunol (2001) 62(11):1191-1199
Hershberger RE, Norton N, Morales A, Li D, Siegfried JD, Gonzalez-Quintana J: Cod-ing sequence rare variants identified in MYBPC3, MYH6, TPM1, TNNC1, and TNNI3 from 312 patients with familial or idiopathic dilated cardiomyopathy. Circ Cardiovasc Genet (2010) 3:155–161
Ho AS, Liu Y, Khan TA, Hsu DH, Bazan JF, Moore KW: A receptor for interleukin 10 is related to interferon receptors. Proc Natl Acad Sci USA (1993) 90:11267-11271
Ho AS, Wei SH, Mui AL, Miyajima A, Moore KW: Functional regions of the mouse interleukin-10 receptor cytoplasmic domain. Mol Cell Biol(1995) 15(9):5043-5053
Hober D, Haque A, Wattre P: Production of tumour necrosis factor-alpha (TNF-alpha) and interleukin-1 (IL-1) in patients with AIDS. Enhanced level of TNF-alpha is related to a higher cytotoxic activity. Clin Exp Immunol (1989) 78(3):329-333
Huang P, Zhou B, Zhang L, Liu X, Chen B, Rao L: The association of IL-2 promoter polymorphisms with idiopathic dilated cardiomyopathy in Chinese Han population.
Zhonghua Yi Xue Yi Chuan Xue Za Zhi. (2008) 25 (3): 322 -325
8. Literaturverzeichnis
Huang QR, Morris D, Manolios N: Identification and characterisation of polymor-phisms in the promoter region of the human Apo-1/Fas (CD95) gene. Mol Immunol (1997) 34:577-582
Hughes SE, McKenna WJ: New insights into the pathology of inherited cardiomyopa-thy. Heart (2005) 91:257-264
Hutchinson IV, Pravica V, Hajeer A, Sinnott PJ. Identification of high and low respond-ers to allografts. Rev Immunogenet (1999) 1:323-333
Ito M, Takahashi H, Fuse K, Hirono S, Washizuka T, Kato K, Yamazaki F, Inano K, Furukawa T, Komada M, Aizawa Y: Polymorphisms of tumor necrosis factor-α and interleukin-10 genes in Japanese patients with idiopathic dilated cardiomyopathy. Jpn Heart J (2000) 41(2):183-191
Jacob CO, Fronek Z, Lewis GD, Koo M, Hansen JA, McDevitt HO: Heritable major histocompatibility complex class II-associated differences in production of tumor necro-sis factor alpha: relevance to genetic predisposition to systemic lupus erythematosus.
Proc Natl Acad Sci U S A. (1990) 87(3):1233-1237
Jacob CO: Tumor necrosis factor alpha in autoimmunity: pretty girl or old witch? Im-munol Today (1992) 13(4):122-125
Jefferies JL, Towbin JA: Dilated cardiomyopathy. Lancet (2010) 375:752–762
Jelinek D, Lipsky P: Enhancement of human B cell proliferation and differentiation by tumor necrosis factor-α: and interleukin I. J Immunol (1987) 139: 2970-2976
Jones EY, Stuart DI, Walker NP: The structure of tumour necrosis factor. Nature (1989) 338 (6212): 225-228
Jongeneel CV, Acha-Orbea H, Blankenstein T: A polymorphic microsatellite in the tu-mour necrosis factor alpha promoter identifies an allele unique to the NZW mouse strain. J Exp Med (1990) 171:2141-2146
8. Literaturverzeichnis
Jue DM, Sherry B, Luedke C, Manogue KR, Cerami A: Processing of newly synthe-sized cachectin/tumor necrosis factor in endotoxin-stimulated macrophages. Biochemis-try (1990) 29: 8371-8377
Kannel WB: Incidence and Epidemiology of Heart Failure. Heart Fail Rev (2000) 5:167-173
Katz SD, Rao R, Berman JW, Schwarz M, Demopoulos L, Bijou R, LeJemtel TH:
Pathophysiological correlates of increased serum tumor necrosis factor in patients with congestive heart failure: relation to nitric oxide–dependent vasodilation in the forearm circulation. Circulation. (1994) 90:12-16
Kapadia S, Lee J, Torre-Amione G, Birdsall HH, Ma TS, Mann DL: Tumor necrosis factor-alpha gene and protein expression in adult feline myocardium after endotoxin administration. J Clin Invest (1995) 96:1042-1052
Kaur K, Sharma AK, Singal PK: Significance of changes in TNF-alpha and IL-10 levels in the progression of heart failure subsequent to myocardial infarction. Am J Physiol Heart Circ Physiol (2006a) 291(1):106-113
Kaur K, Sharma AK, Dhingra S, Singal PK: Interplay of TNF-alpha and IL-10 in regu-lation oxidative stress in isolated adult cardiac myocytes. J Mol Cell Cardiol (2006b) 41(6):1023-1030
Kaur K, Dhingra S, Slezak J, Sharma AK,Bajaj A, Singal PK: Biology of TNF alpha and IL-10, and their imbalance in heart failure. Heart Fail Rev (2009) 14(2):113-123
Kim JM, Brannan CI, Copeland NG, Jenkins NA, Khan TA, Moore KW: Sructure of the mouse IL- I0 gene and chromosomal localization of the mouse and human genes. J Immunol (1992) 148(11): 3618-3623
Kinkhabwala M, Sehajpal P, Skolnik E, Smith D, Sharma VK, Vlassara H, Cerami A, Suthanthiran M: A novel addition to the T cell repertory. Cell surface expression of
tu-8. Literaturverzeichnis
mor necrosis factor/cachectin by activated normal human T cells. J Exp Med (1990) 171(3): 941-946
Kishimoto T, Taga T, Akira S: Cytokine Signal Transduction. Cell (1994) (76): 253-262
Kehrl JH, Miller A, Fauci AS: Effect of tumor necrosis factor alpha on mitogen-activated human B cells. J Exp Med (1987) 166:786-791
Kelly RA, Smith TW: Cytokines and cardiac contractile function. Circulation (1997) 95(4):778-781
Khatri VP, Caligiuri MA: A review of the association between interleukin-10 an human B-cell malignancies. Cancer Immunol Immunother (1998) 46(5):239-244
Klappacher G, Mundigler G, Papousek A, Pacher R, Woloszczuk W, Ulrich R, Buxbaum P, Glogar D: Elevated circulating levels of b 2-microglobulin in patients with idiopathic dilated cardiomyopathy. Am J Cardiol (1993) 71:119-122
Koch W, Kastrati A, Bottiger C, Mehilli J, von Beckerath N; Schomig A: Interleukin-10 and tumor necrosis factor gene polymorphisms and risk of coronary artery disease and myocardial infarction. Atherosclerosis (2001) 159:137
Kotenko SV, Krause CD, Izotova LS, Pollack BP, Wu W, Pestka S: Identification and functional characterization of a second chain of the interleukin-10 receptor complex.
EMBO J (1997) 16(19):5894-5903
Kriegler M, Perez C, DeFay K, Albert I, Lu SD: A novel form of TNF/cachectin is a cell surface cytotoxic transmembrane protein: ramifications for the complex physiology of TNF. Cell (1988) 53:45-53
Kroeger KM, Steer JH, Joyce DA, Abraham LJ: Effects of stimulus and cell type on the expression of the -308 TNF-a promoter polymorphism. Cytokine (2000)12(2):110-109
8. Literaturverzeichnis
Kube D, Platzer C, von Knethen A, Straub H, Bohlen H, Hafner M, Tesch H: Isolation of the human interleukin 10 promoter. Characterization of the promoter activity in Bur-kitt's lymphoma cell lines. Cytokine. (1995) 7(1):1-7
Kubota T, McTiernan CF, Frye CS, Slawson SE, Lemster BH, Koretsky AP, Demetris AJ, Feldman AM: Dilated cardiomyopathy in transgenic mice with cardiac-specific overexpression of tumor necrosis factor-alpha. Circ Res (1997) 81:627-635
Kühl U, Pauschinger M, Noutsias M, Seeberg B, Bock T, Lassner D, Poller W, Kandolf R, Schultheiss HP: High prevalence of viral genomes and multiple viral infections in myocardium of adults with “idiopathic” left ventricular dysfunction. Circulation. (2005) 111(7):887-893
Lacraz S, Nicod LP, Chicheportiche R, Welgus HG, Dayer JM: IL-10 inhibits metallo-proteinase and stimulates TIMP-1 production in human mononuclear phagocytes. J Clin Invest (1995) 96:2304-2310
Lai CF, Rupperger J, Morella KK, Jurlander J, Hawley TS, Carson WE, Kordula T, Caligiuri MA, Hawley RG, Fey GH, Baumann H: Receptors for interleukin (IL)-10 and IL-6-type cytokines use similar signaling mechanisms for inducing transcription through IL-6 response elements. J Biol Chem (1996) 271(24):13968-13975
Lalani I, Bhol K, Ahmed AR: Interleukin-10: biology, role in inflammation and auto-immunity. Ann Allergy Asthma Immunol (1997) 79(6):469-483
Lazarus M, Hajeer AH, Turner D, et al. Genetic variation in the interleukin 10 gene promoter and systemic lupus erythematosus. J Rheumatol (1997) 24:2314–2317
Levine B, Kalman J, Mayer L, Fillit HM, Packer M: Elevated circulating levels of tu-mor necrosis factor in severe chronic heart failure. N Engl J Med (1990) 323: 236–241
Li YY, Feng YQ, Kadokami T, McTiernan CF, Draviam R, Watkins SC, Feldman AM:
Myocardial extracellular matrix remodeling in transgenic mice overexpressing tumor
8. Literaturverzeichnis
necrosis factor alpha can be modulated by anti-tumor necrosis factor alpha therapy. Proc Natl Acad Sci USA (2000) 97(23):12746-12751
Liang WB, Lv ML, Su XW, Gao LB, Fang WL, Luo HB, Zhang L: Association of tu-mor necrosis factor gene polytu-morphisms with susceptibility to dilated cardiomyopathy in a Han Chinese population. DNA Cell Biol (2010) 29 (10): 625-628
Lio D, Scola L, Crivello A, Colonna-Romano G, Candore G, Bonafè M, Cavallone L, Franceschi C, Caruso C: Gender-specific association between -1082 IL-10 promoter polymorphism and longevity. Genes Immun (2002) 3(1):30-33
Lio D, Licastro F, Scola L, Chiappelli M, Grimaldi LM, Crivello A, Colonna-Romano G, Candore G, Franceschi C, Caruso C: Interleukin-10 promoter polymorphism in spo-radic Alzheimer's disease. Genes Immun (2003) 4(3):234-238
Liu Y, Wei SH-Y, Ho AS-Y, de Waal Malefyt R, Moore KW: Expression cloning and characterization of a human interleukin-10 receptor. J Immunol (1994) 152:1821-1829
Liu Y, de Waal Malefyt R, Briere F, Parham C, Bridon J-M, Banchereau J, Moore KW, Xu J: The Epstein-Barr virus interleukin-10 (IL-10) homolog is a selective agonist with impaired binding to the IL-10 receptor. J Immunol (1997) 158:604-613
Loetscher H, Pan YC, Lahm HW, Gentz R, Brockhaus M, Tabuchi H, Lesslauer W.
Molecular cloning and expression of the human 55 kd tumor necrosis factor receptor.
Cell (1990) 61:351–9
Louis E, Franchimont D, Piron A, Gevaert Y, Schaaf-Lafontaine N, Roland S, Mahieu P, Malaise M, De Groote D, Louis R, Belaiche J: Tumour necrosis factor (TNF) gene polymorphism influences TNF-alpha production in lipopolysaccharide (LPS)-stimulated whole blood cell culture in healthy humans. Clin Exp Immunol (1998) 113(3):401-406
Louis A, Cleland JG, Crabbe S, Ford S, Thackray S, Houghton T, Clark A: Clinical trials update. Eur J Heart Fail (2001) 3:381-387